atosis) of the liver is common in asymptomatic obese persons : fatty infiltration (fatty liver, fatty hepatitis and fatty cirrhosis) of the liver is reported to develop in up to 90% of them 1 ) . Although it is unclear, there have been many proposed mechanisms of fatty liver. One of the proposed mechanisms is that hyperinsulinemia, which reflects insulin resistance in obese persons, is associated with development of fatty liver in obes ity 2 ) . This hypothesis is based on the observation that steatos is and steatohepatitis occur in subcapsular liver of type I diabetic patients treated with intraperitoneal insulin delivery 3 ) . In a recent
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report, risk factor analysis in a large scale autopsy study indicates that obesity, non-insulin dependent diabetes and intravenous glucose therapy are associated with severe steatosis and steatohepatitis, which suggest the possibility that hyperinsulinemia may have a role in the pathogenesis of fatty liver 4 ) . It is believed that relative ins ulin secretion in patients with hyperinsulinemia and ins ulin resistance may eventually decrease and impaired glucose tolerance (IGT) and diabetes may occur, which also predispose the development of fatty liver 5 ) .
Some non-obese persons may also develop fatty liver or fatty hepatitis even though the incidence is not as high as in obese persons 4 , 6 ) . However, there is no report regarding the pathogenesis of fatty liver in non-obese persons. We assumed the fact that some non-obese persons can also develop insulin resistance leading to hyperinsulinemia, and glucose intolerance 7 ) may have an association with the development of fatty liver in non-obese persons. In this study, we aimed to elucidate whether hyperinsulinemia, and glucose intolerance, as consequences of insulin resistance, are associated with the development of fatty liver in patients with normal body weight.
MA T E R IA LS A N D MET HO D S 1. Patients
From March 1996 to September 1996, 47 patients with fatty liver (25 non-obese, 22 obese) who visited the Samsung Medical Center were enrolled in the study. Obesity was defined when the body mass index (BMI was 25 kg/m 2 or more in patients aged 19 to 24 years old and adding 1 kg/m 2 as the age increases by 10 years 8 ) .
Inclusion criteria were as follows: elevated transaminase levels during more than 3 months of follow-up period, absence of HBsAg by radioimmunoassay (Ausria R , Abbot Laboratories , USA) or anti-HCV by third generation enzyme-linked immunosorbent assay (Lucky HCD R 3.0, Lucky Pharmaceutical Div., Korea) in the serum, alcohol consumption less than 40 gm/week, no use of potential hepatotoxic drugs within 3 months prior to visit, and moderate to severe fatty infiltration of the liver by ultrasonography according to the Soatarige s criteria 9 ) .
La boratory Eva luation
Liver function tests and serum lipid profiles were checked in all patients included in the study. Baseline fasting insulin levels were measured by radioimmunoas- There was no difference in alkaline phosphatase (ALP), aspartate aminotransferase (AST), alanine aminotransferase, gamma-glutamyl transferase ( -GT) levels between the two groups. Although there was a trend toward increased levels of triglyceride in the obese group, there was no statistical difference in lipid profile between the two groups ( Table 2 ).
Base line ins ulin leve ls
Mean baseline insulin levels were elevated above the reference value in both groups, 9.3 3.5 U/L in the non-obese group and 9.9 3.5 U/L in the obese group (Fig. 1) , with no statistical difference (p= 0.26). Seventeen of the non-obese patients (68%) and 16 of the obese patients (73%) had elevated basal insulin level: there was no statistical difference (p=0.39) in the proportion of patients with high ins ulin level between the two groups ( Table 3) . 4. Ora l glucose tole rance test
There was no difference in glucose levels between non-obese and obese groups from 0 minute to 180 
Ta ble 4 . Fre que ncy of Impa ire d Gluc o s e To le ra nc e o r Dia be te s .
IGT or diabetes Norma l Non-obese (Fig. 2) . Eleven patients (7 IGT, 4 diabetes, 44%) from the non-obese group and 8 patients (4 IGT, 4 diabetes , 36%) from the obese group had either IGT or diabetes . There was no difference in the frequency of abnormal glucose tolerance test (p=0.29) between the two groups ( Table 4) .
Tab le 2 . Live r Functio n te s ts a nd lip id Profile s
Non-obese (n=25) Cross chi-square test was performed to see the relationship between the hyperinsulinemia and glucose intolerance, which showed that insulin level and glucose intolerance did not mutually affect each other (Table 5) . Overall, 20 out of 25 non-obese patients (80.0%) and 18 out of 22 obese patients (81.8%) with fatty liver had either hyperinsulinemia, glucose intolerance, or both.
D IS C US S IO N
Although understanding of the mechanism causing fatty liver and its consequence is lacking at this point, a unifying hypothesis that might explain hepatic triglyceride accumulation is now possible based on our knowledge of fatty acid and triglyceride metabolism 1 1) . Fat continuously cycles between peripheral stores and the liver, and any relatively minor perturbation in this process can substantially alter the dynamic equilibrium established under normal conditions 11) . It is now apparent that the accumulation of fat in the liver can be attributed to aberration in at least one of the four basic processes as fat is cycled between hepatocyte and adipose tissue: 1 1, 12 ) (1) increased fatty acid delivery to the liver, (2) increased free fatty acid synthesis within the liver, (3) decreased oxidation of fatty acids and (4) decreased very low density lipoprotein synthesis or secretion.
One of the possible contributing factors that can alter the fat equilibrium is insulin: insulin inhibits oxidation of fatty acid 13) and this effect might lead to increased cellular level of toxic free fatty acid which in turn causes hepatocyte injury. Obesity is one of the most common causes of insulin resistance and up to 85% of obese persons without overt diabetes (> 30% of ideal body weight) are known to have high insulin level to overcome ins ulin resistance 7 ) . From these facts, hyperins ulinerma is generally accepted as a causative factor associated with development of fatty liver in obesity. Hyperinsulinemia and glucose intolerance, although not as frequent as in obese persons, has also been known to develop in some non-obese s ubjects 14 ) which can possibly explain the development of fatty liver in these subjects. We were able to prove our hypothes is that hyperinsulinemia may be associated with development of fatty liver in non-obese s ubjects, because both mean basal insulin level and the frequency of hyperinsulinemia in non-obese subjects were similar to obese subjects.
In Korea, prevalence of impaired glucose tolerance and diabetes in the general population over the age of 30 is reported to be 8% and 12 %, respectively 15 ) . We had about a two-fold higher rate of impaired glucose tolerance or diabetes (44% in non-obese group, 36% in obese group) in patients who did not have elevated fasting serum glucose level, suggesting the role of glucose intolerance in the pathogenesis of fatty liver in patients without documented diabetes . S ince there are reported cases of fatty liver or fatty hepatitis preceding the onset of overt diabetes 16 ) , early detection of IGT and diabetes without fasting hyperglycemia in patients with fatty liver can have important clinical meaning in terms of patient management. Our data regarding the high prevalence of glucose intolerance among fatty liver patients might justify routine application of glucose tolerance test in the evaluation of the patients with fatty liver, since results of abnormal glucose tolerance test warrant more strict management, such as control of body weight, exercise etc. Ultrasonography is reported to have about 60% sensitivity in diagnosis of fatty liver 17 ) , but is reported to have up to 97% accuracy correlated to liver biopsy 18 ) .
Although clinical utility of sonographic diagnosis of fatty liver in alcoholics is known to have limited clinical value, s ince cirrhosis can coexist with fatty liver, sonographic detection of fatty liver in nonalcoholic patients is reported to provide relevant clinical information that explain abnormal liver function tests 19 ) . In this study, diagnos is of fatty liver was made by ultrasonography and clinical and laboratory exclusion of alcoholic liver disease, viral hepatitis and drug induced liver injury. One of the pitfalls in our diagnos is could be that we might have missed some mild cases of fatty liver which are not detected by ultrasonography due to low sensitivity. Although ultrasonography has some limitations in distinguis hing fatty liver from cirrhosis 9 ) , none of our patients s howed stigmata of chronic liver disease or laboratory abnormalities that s uggest cirrhosis, and it is very unlikely that these patients had cirrhosis. However, accurate quantitation of fatty infiltration was not possible without liver biopsy and correlation of fatty infiltration and degree of hyperins ulinemia could not be performed, which could be one of the limitations of our study. Another limitation of diagnos ing fatty liver with ultrasonography is that differentiation of simple fatty liver and nonalcoholic steatohepatitis and/or fibrosis was not possible. Our cases might have included a s ignificant number of nonalcoholic steatohepatitis cases since 15-30% of obese and person, 1. 2 , 4) and a few non-obese persons 6 , 20 ) are reported to have non-alcoholic steatohepatitis. Since nonalcoholic steatohepatitis is reported to progress to liver cirrhosis 6 , 20 ) , whereas simple fatty liver usually has favorable prognosis 2 ) , differentiation of the two would have put more clinical implication to our data. This study can be considered as a preliminary study to upcoming studies that include liver biopsies and more sophisticated methods that measures insulin resistance, overcoming the limitations of this study.
Our data suggest that a large percentage of patients with fatty liver have abnormalities in glucose metabolism, such as hyperinsulinemia and glucose intolerance, irrespective of obesity. In conclusion, we suggest that hyperins ulinemia and glucose intolerance may play a role in the pathogenes is of fatty liver in patients with normal body weight as well as in patients with obesity.
